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Abstract. Bronchial hyperresponsiveness (BHR) can be considered as a fea- 
ture of asthma, although only a loose relationship is present with symptoms 
and severity of the disease. Epidemiology of BHR may inform about deter- 
mining factors in BHR and its role as a risk factor. BHR is found already at a 
young age, mostly diminishes with age, and increases in many asthmatic 
patients after midlife. Genetic determinants are suggested by familial segre- 
gation and twin studies. Allergy, respiratory infections, and cigarette smok- 
ing are found to induce increase in BHR and to modify its degree at the long 
run. The mechanisms in BHR are being unraveled gradually. A chronic 
inflammation with an important role for eosinophils, mast cells, and others, 
is thought o modify bronchial mechanisms, uch as smooth muscle, epithe- 
lium, and autonomic systems. Growing evidence supports that T lympho- 
cytes are implicated and may determine many of the inflammatory cells, 
such as eosinophils, neutrophils, and mast cells. 
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Introduction 
The majority of asthmatic patients are found to have bronchial hyperreactivity 
(BHR) and this phenomenon is clearly a central feature of the pathophysiology 
of asthma. BHR is related to the occurrence and severity of asthmatic symp- 
toms in general and to the bronchial reaction after various timuli such as 
allergens, exercise, and cold air. A wealth of information has been accumulated 
about clinical aspects of BHR, but still relatively modest knowledge is present 
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about factors that influence BHR and about basic regulating processes. This 
presentation aims to consider the rapidly growing information about these as- 
pects. 
Epidemiologic Studies 
The relationship of BHR with age and various variables may inform us about 
factors that determine or influence BHR. 
BHR is found to be present already in very young children. Infants seem to 
have pronounced BHR. Le Souef et al. [1] found bronchial obstruction after 
relative low doses of histamine, using a chest squeezing technique. Similar 
findings have been found by Tepper [2]. These findings are consistent with the 
concept hat infants are born with BHR or develop it soon after birth. The 
course of BHR from infancy into adulthood has been considered by Australian 
investigators. It was estimated that BHR decreased, but largely persisted and 
that about 60% of the subjects who had ceased wheezing still had BHR [3]. 
Gerritsen et al. [4] found a decrease in BHR in about wo thirds and an increase 
in about one third of the patients in their adulthood as compared to BHR in 
their childhood (between 6.14 years of age). BHR in adulthood was related to 
lung function values in childhood and age of onset of respiratory symptoms. 
They concluded that the outcome of childhood asthma was primarily predicted 
by the initial degree of bronchial obstruction and BHR. 
BHR appears to decline with age during childhood and early adulthood 
until reaching its lowest level during the fifth decade according to a study by 
Hopp et al. [5]. Subsequently, BHR increases with age during the sixth and 
seventh decades. Rijcken et al. [6] concluded from a large Dutch population 
study that BHR increased with age. 
In a study of adults between 18 and 64 years of age BHR was found to 
increase strikingly with age among cigarette smokers, but actually decreased in
atopic nonsmokers, perhaps reflecting the waning of atopy in advancing years. 
Adjustment for the level of pulmonary function is necessary for comparison of 
a wide range of BHR values, which is not well taken care for in most epidemio- 
logic studies. This seriously compromises the conclusions and comparison be- 
tween studies. 
A concept may be constructed implying a high degree of BHR in young 
children which decreases slightly in part of them into adulthood. In the second 
half of life an increase in BHR can be observed in association with smoking and 
possibly other factors. Along with atopy, BHR actually decreased with age. 
Genetic Factors 
Duiverman et al. [7] studied groups of young children. A relatively high degree 
of BHR is present in asthmatic children, whereas anormal or slight degree was 
found in healthy children. Children without asthma who have borderline BHR 
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turned out to have a positive family history for asthma nd asthmatic hildren 
with a relatively low degree of BHR had a negative family history. The study of 
Duiverman and others points to a genetic determinant in the occurrence of 
BHR. Heredity as a factor in BHR is also suggested by twins and family 
aggregation data. Konig and Godfrey [8] have demonstrated a greater intrapair 
correlation of exercise-induced bronchus obstruction in monozygotic than 
among dizygotic twins. Hopp et al. [9] confirmed this in a relatively large 
selected population of twins, which was not the case in a small study by Zamel 
and colleagues [10]. Familial aggregation of BHR has been assessed in families 
of persons with asthma. Healthy relatives of asthma patients and infants with 
wheezy bronchitis were found to have an increased occurrence of exercise- 
induced bronchus obstruction [11]. Also Townley et al. [12, 13] reached these 
conclusions. These human studies are in accordance with animal data involving 
rats [14] and dogs [15]. 
Thus, there is clearly an heritability component in BHR, but the genetic 
character is probably multifactorial and not likely to be dependent on a single 
gene. Longo et al. [16] found information to suggest them an autosomal-domi- 
nant pattern of inheritance. 
Environmental Influences 
A number of variables have been identified that are able to modify BHR, such 
as allergen reactions, viral infections, smoking, and polluted air. These factors 
are found to induce a temporarily increase in BHR, but their role in the genera- 
tion of a persistent rise is less certain and awaits further study. 
Allergy clearly has an effect on BHR, but the relationship between them is 
complicated. Allergen challenge and longitudinal studies with challenging and 
nonchallenging periods have indicated that BHR may increase due to an aller- 
gic late reaction in asthmatics. In population studies BHR is found to be associ- 
ated with the presence of sensitization to common allergens [17-19]. 
Allergy and BHR may be connected either by genetically linked traits, or 
may interact by cellular and metabolic processes or both. Allergen-induced 
mediators, such as histamine and leukotrienes, as well as cell action by eosino- 
phils and others, might well sensitize the bronchial mechanism to react in an 
augmented way. 
Acute respiratory infections early in life (bronchiolitis, pneumonia) were 
found to be associated with the presence of BHR later on, in a study by Weiss 
and colleagues [20]. Those subjects who had croup or bronchiolitis or had 
repeated lower respiratory illnesses, had increased bronchial responsiveness a  
compared to those subjects who did not had such respiratory diseases. No 
clear relationship was~detected between the presence of acute lower respira- 
tory illness and atopy. 
These and other observations suggest an interrelationship between infec- 
tions, in particular bronchiolitis and BHR. This is not the case with aspecific 
lung injury in a random population. Several studies how that lung injury per se 
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is not sufficient for induction of BHR, and that a genetic predisposition is
probably necessary. 
Cigarette smoking may cause heightened airway responsiveness, but this 
relationship seems to be evident only among persons with a sufficiently high 
cumulative exposure. This could be concluded from Burney et al. [19], 
Woolcock et al. [21], and Sparrow et al. [22], but not by the group of Van der 
Lende [23] which might be explained by a relatively low dose of smoking and 
the young mean age in this study. 
A number of plausible mechanisms can be proposed for a direct causal 
relationship between smoking and BHR, namely, chronic airway inflammation, 
airway epithelial damage, and smoking-induced reduction in lung function. 
The susceptibility o induce an increase in BHR and the development of 
chronic lung disease by all those environmental variables eems to be depen- 
dent, at least partially, on host factors. These factors are still difficult to define. 
The initial degree of BHR has been found to reflect a risk factor by several 
studies. This is substantiated by the studies of Postma et al. [24], who provided 
evidence indicating that the degree of BHR is related to the gradual loss in lung 
function. The decline in lung function is greater along with a higher degree of 
BHR. 
The following concept of BHR is supported by all this information. An 
endogenous component is present in BHR, which is probably largely geneti- 
cally determined. In addition, certain environmental variables may induce a 
further augmentation i  BHR. This susceptibility is probably dependent on host 
factors that are highly associated with the presence of asthma and probably 
linked to the genetic system. 
Mechanisms of BHR 
The causes of BHR are being unraveled step by step, although the responsible 
basic abnormality is still not elucidated. Along with research progress three 
stages can be considered. 
Anatomic and Functional Modifications in Bronchial Systems 
Anatomical and functional modifications in bronchial systems directly regulate 
bronchial diameter. Some reports produce vidence that airway smooth muscle 
from asthmatics exhibited increased contractile responses in vitro to agonists 
(histamine, methacholine and leukotriene C4) as compared to that of healthy 
controls [25, 26]. However, few true asthmatics have been studied in this way. 
Airway smooth muscle hyperplasia is present even i  relatively mild asth- 
matics, possibly as a result of various growth factors released from inflamma- 
tory cells, such as platelet-derived and macrophage-derived growth factors. It 
seems likely the hyperplasia of airway smooth muscle would contribute to 
airway hyperrresponsiveness, and may explain the persistence of bronchial 
hyperresponsiveness after inflammation has subsided. 
272 H.J. Neijens 
Autonomic nervous control of the airways is complex and several studies 
have investigated the possibility hat defects in autonomic ontrol may contrib- 
ute to bronchial hyperresponsiveness and the pathology of asthma. Several 
abnormalities of autonomic function, such as enhanced cholinergic and a-ad- 
renergic responses or reduced/3-adrenergic responses, have been proposed. 
Current thinking suggests that these abnormalities are likely to be second- 
ary to the disease, rather than primary defects. It is possible that airway inflam- 
mation may interfere with autonomic ontrol by several mediators and mecha- 
nisms [27]. 
Airway epithelial damage may be a critical feature of BHR and may explain 
how several different mechanisms, uch as allergen exposure, virus infection, 
and ozone exposure, can lead to its development, since all these stimuli may 
lead to epithelial disruption. Epithelial disruption may contribute to BHR in a 
number of ways. Mechanical removal of epithelial cells in vitro results in in- 
creased responsiveness of airway smooth muscle to spasmogens [28, 29] and 
suggests that epithelial cells may release a relaxant factor by analogy with 
endothelial-derived relaxant factor in vessels. Damage of epithelium would 
thus remove the protective effect of this relaxant factor, leading to exaggerated 
bronchoconstrictor responses. Epithelial cells themselves may release inflam- 
matory mediators, such as leukotriene B4 and 15-HETE, which is chemotactic 
for inflammatory cells [30]. Epithelial damage will also expose sensory nerve 
endings, which may be activated by inflammatory mediators, leading to inflam- 
mation via an axon reflex mechanism [31]. 
Inflammatory Processes in the Bronchi 
There is now considerable experimental evidence that induced BHR is associ- 
ated with inflammation i  the airways [32]. Histopathologic studies from asth- 
matic patients who have died during asthma ttacks how that there is marked 
inflammation i  the airways, with infiltration of inflammatory cells, particularly 
eosinophils, disruption of airway epithelium and mucus hypersecretion [33]. 
Similar pathologic hanges have also been found in bronchial biopsies from 
asthmatics who are relatively mild [34] and suggest hat airway inflammation 
may underlie BHR. 
By bronchoalveolar lavage (BAL) several cell types are found, especially 
after provocation; these cells are eosinophils, neutrophils, mast cells, and lym- 
phocytes. Wardley et al. [34] found an inverse relationship between BHR 
(PC20) and the percentage of mast cells, eosinophils, epithelial cells, and the 
amount of MBP. It now seems likely that several different cells are involved in 
the pathogenesis ofasthma, and that these cells Produce a variety of mediators 
that interact in a complex way to produce a number of pathologic effects that, 
together, contribute to BHR. 
Macrophages are present hroughout the respiratory tract, and the recent 
demonstration that they may be activated by IgE-dependent mechanisms has 
suggested that they may be involved in asthmatic inflammation [36]. They have 
the potency to produce and release a variety of mediators. Macrophages from 
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asthmatics release increased amounts of mediators, such as thromboxane, pro- 
staglandins, and platelet-activating factor (PAF). 
Histologic studies suggest hat eosinophil infiltration is a feature of asth- 
matic airways and differentiates asthma from other inflammatory conditions. 
Allergen inhalation results in a marked increase in eosinophils in bronchoal- 
veolar lavage fluid at the time of the late reaction [37], and there is a relation- 
ship between peripheral eosinophilia nd bronchial hyperresponsiveness [38]. 
Eosinophils release a variety of mediators, including leukotriene C4 and 
PAF, and basic proteins such as major basic protein, eosinophil cationic pro- 
tein and eosinophil-derived neurotoxin, that are toxic to airway epithelium and 
other structures. 
Neutrophil infiltration is characteristic of some animal models of asthma 
[39]. Neutrophils are particularly related to provocation with toxic factors such 
as ozone [40] and industrial agents, but are also found shortly after allergen 
inhalation before the eosinophils arrive. Although neutrophils are found to 
produce factor(s) that may induce BHR [41], their role in human ~isthma is less 
certain [42]. 
Many different mediators have been implicated in asthma and they may 
have a variety of affects on the airways that account for many of the pathologic 
features of asthma. Thus, mediators uch as histamine, prostaglandins, and 
leukotrienes contract irway smooth muscle, increase microvascular leakage, 
increase mucus secretion, and attract other inflammatory cells. It is therefore 
possible that interaction between inflammatory mediators might account for 
BHR. 
PAF, like antigen, stimulates accumulation of eosinophils in lung [43] and 
in the skin of atopic subjects [44]. This selective attraction of eosinophils might 
explain how PAF can produce such a prolonged increase in responsiveness, 
since eosinophils may lead to damage and shedding of airway epithelium as 
discussed above. Since eosinophils themselves are a rich source of PAF  [45], 
they can attract further eosinophils and there is the potential for a continued 
inflammation. PAF has other properties that may be relevant in asthma. In 
animals, PAF is a potent inducer of airway microvascular leak, being the most 
potent agent so far described [46]. This may lead to airway edema and plasma 
extravasation which may be involved in the creation of BHR [47]. 
Imrnunoregulating Factors 
The study of immunoregulating factors is the final step in the elucidation of the 
mechanisms and this approach has just started. The concept is that immune 
factors related to T lymphocytes have an important role to regulate cellular 
responses by eosinophils and other aspecific ells and thus determine the oc- 
currence and degree of bronchial inflammation. 
Infiltration by T lymphocytes (CD~/CD~) together with T-cell activation 
(IL-2 receptor) was found in association with allergen-induced late-phase skin 
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reaction in human atopic subjects by Frew et al. [48]. These changes were 
accompanied by eosinophil infiltration and activation. 
Bronchoalveolar lavage studies of the human late asthmatic reaction have 
revealed the presence of increased numbers of eosinophils and lymphocytes 
during the late response, whereas no such changes were seen in isolated early 
responders [49]. Gonzalez et al. [50] studied T-cell subsets in BAL and blood. 
BAL lymphocytes increased until 6-12% of the cells in both BAL and blood 
isolated early and ual responders after allergen challenge. In the dual respond- 
ers CD4 and CD8 increased, whereas in the isolated early reactions no change in 
CD8 and thus decrease in the 4 : 8 ratio was present in BAL. The absence of a 
CD8 rise in late-phase responders raises the possibility that CD8 T lymphocytes 
control the occurrence of late bronchial reactions. 
Effects of T-cell activation have been found in several other cell types, 
namely, IL-2 and HLA-DR receptor activation on endothelial cells and CD4 
antigen on epidermal Langhans cells. Both provide indirect evidence of ~/- 
interferon secretion from activated T cells. A strong association was detected 
linking CDg T lymphocyte numbers with the number of activated eosinophils in 
the study by Frew et al [48]. 
These findings suggest hat CD~- T lymphocytes are attracted to sites of 
allergic inflammation and that these ceils and their products may contribute o
the pathogenesis of chronic allergic inflammation. Cytokines such as ~/-inter- 
feron have many actions, including activation of macrophages for subsequent 
elaboration of eosinophil activation factors. There have been several reports of 
a defect in suppressor cell function in asthma [51, 52]. CD~- T cells produce a 
histamine-induced suppressor factor that inhibits lymphocyte proliferation and 
lymphokine production. 
The clinical relevance of T lymphocytes in asthma is further supported by 
the observation showing that the number of T lymphocytes expressing HLA- 
DR and IL-2 receptors indicating cell activation, was increased with exacerba- 
tions [53]. 
A growing body of information suggests that eosinophil differentiation and 
proliferation is controlled by cytokines including IL-5- and T-lymphocyte-de- 
rived eosinophil colony stimulating factors both in humans and animals [54- 
56]. 
An action of T lymphocytes on neutrophil activation was put forward by 
Tsai et al. [57] who detected a lymphocyte-derived factor. After induction by 
anti-CD4 antibodies, LTB4 generation by neutrophils increased by 15%- 
350%. 
Good evidence supports now that T lymphocytes are present and active in 
allergic reactions in the skin and in the bronchi. T lymphocytes are found to 
have the potency to induce eosinophil, neutrophil, and macrophage activation, 
for which actions in vivo evidence has been detected. Inadequate actions of 
CD~- T lymphocytes, probably a specific subset, might also be critical in asth- 
matic reactions. Since the actions of T lymphocytes are under control of im- 
munoresponse g nes, genetic factors might well guide asthmatic reactions and 
BHR along this line. 
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